Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Invested Capital (2010 - 2026)

Innoviva's (INVA) quarterly Invested Capital came in at $191.9 million in Q2 2025, little changed on a QoQ basis from $192.2 million in Q1 2025.

Analysis

Innoviva (INVA) Invested Capital (2010 - 2026) Analysis & Trends

Innoviva (INVA) has 14 years of Invested Capital data on file, last reported at $191.9 million in Q2 2025.

  • Quarterly Invested Capital changed N/A year-over-year to $191.9 million in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $191.9 million (down 66.69% YoY) and the FY2024 annual result came in at $192.0 million, changed N/A from the prior year.
  • Invested Capital held at $191.9 million in Q2 2025, from $192.2 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $433.5 million in Q2 2021 to a low of $96.0 million in Q1 2022.
  • A 4-year average of $201.9 million and a median of $191.9 million in 2024 frame the typical range for Invested Capital.
  • Annual changes were most pronounced in 2021 — Invested Capital changed 0.0% — and 2022, when it plunged 77.84%.
  • Tracing INVA's Invested Capital over 4 years: stood at $433.5 million in 2021, then sank by 77.81% to $96.2 million in 2022, then surged by 99.63% to $192.0 million in 2024, then dropped by 0.07% to $191.9 million in 2025.
  • The last three Invested Capital figures came in at $191.9 million (Q2 2025), $192.2 million (Q1 2025), and $192.0 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn 1.49 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.49 Bn
Mar 31, 2026 1.60 Bn
Dec 31, 2025 1.43 Bn
Sep 30, 2025 1.27 Bn
Jun 30, 2025 1.16 Bn
Mar 31, 2025 1.10 Bn
Dec 31, 2024 1.14 Bn
Sep 30, 2024 1.12 Bn
Jun 30, 2024 1.11 Bn
Mar 31, 2024 1.15 Bn
Dec 31, 2023 1.12 Bn
Sep 30, 2023 1.07 Bn
Jun 30, 2023 1.00 Bn
Mar 31, 2023 1.01 Bn
Dec 31, 2022 1.11 Bn
Sep 30, 2022 1.18 Bn
Jun 30, 2022 661.53 Mn
Mar 31, 2022 648.23 Mn
Dec 31, 2021 920.59 Mn
Sep 30, 2021 884.10 Mn